Fidelity Investments’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.05M | Buy |
36,848
+18,071
| +96% | +$1.45M | ﹤0.01% | 2608 |
|
|
2026
Q1 | $1.44M | Buy |
18,777
+8,920
| +90% | +$696K | ﹤0.01% | 2741 |
|
|
2025
Q4 | $778K | Sell |
9,857
-25,237
| -72% | -$2.19M | ﹤0.01% | 2944 |
|
|
2025
Q3 | $3.21M | Buy |
35,094
+31,459
| +865% | +$2.57M | ﹤0.01% | 2382 |
|
|
2025
Q2 | $237K | Buy |
3,635
+59
| +2% | +$3.84K | ﹤0.01% | 3247 |
|
|
2025
Q1 | $239K | Buy |
3,576
+485
| +16% | +$29K | ﹤0.01% | 3177 |
|
|
2024
Q4 | $171K | Sell |
3,091
-15,310
| -83% | -$879K | ﹤0.01% | 3330 |
|
|
2024
Q3 | $1.1M | Buy |
18,401
+3,972
| +28% | +$242K | ﹤0.01% | 2569 |
|
|
2024
Q2 | $919K | Buy |
14,429
+13,885
| +2,552% | +$901K | ﹤0.01% | 2546 |
|
|
2024
Q1 | $37.6K | Buy |
544
+50
| +10% | +$3.02K | ﹤0.01% | 3732 |
|
|
2023
Q4 | $27.3K | Buy |
494
+3
| +0.6% | +$165 | ﹤0.01% | 3795 |
|
|
2023
Q3 | $28.5K | Buy |
491
+35
| +8% | +$2.02K | ﹤0.01% | 3632 |
|
|
2023
Q2 | $24.5K | Buy |
456
+161
| +55% | +$7.14K | ﹤0.01% | 3751 |
|
|
2023
Q1 | $11.7K | Buy |
295
+13
| +5% | +$548 | ﹤0.01% | 4067 |
|
|
2022
Q4 | $11.3K | Sell |
282
-72
| -20% | -$2.7K | ﹤0.01% | 3966 |
|
|
2022
Q3 | $11K | Buy |
354
+266
| +302% | +$9.11K | ﹤0.01% | 4043 |
|
|
2022
Q2 | $2K | Sell |
88
-49
| -36% | -$1.41K | ﹤0.01% | 4526 |
|
|
2022
Q1 | $4K | Buy |
+137
| New | +$5.11K | ﹤0.01% | 4471 |
|
|
2021
Q3 | – | Sell |
-12
| Closed | – | – | 4292 |
|
|
2021
Q2 | $0 | Buy |
+12
| New | +$408 | ﹤0.01% | 4195 |
|
|
2021
Q1 | – | Sell |
-246
| Closed | -$7K | – | 3949 |
|
|
2020
Q4 | $7K | Sell |
246
-27
| -10% | -$773 | ﹤0.01% | 3370 |
|
|
2020
Q3 | $8K | Buy |
273
+27
| +11% | +$804 | ﹤0.01% | 3214 |
|
|
2020
Q2 | $8K | Hold |
246
| – | – | ﹤0.01% | 3153 |
|
|
2020
Q1 | $10K | Sell |
246
-764
| -76% | -$40.6K | ﹤0.01% | 3106 |
|
|
2019
Q4 | $62K | Sell |
1,010
-3
| -0.3% | -$199 | ﹤0.01% | 2847 |
|
|
2019
Q3 | $74K | Buy |
1,013
+1
| +0.1% | +$75 | ﹤0.01% | 2794 |
|
|
2019
Q2 | $83K | Buy |
1,012
+12
| +1% | +$853 | ﹤0.01% | 2774 |
|
|
2019
Q1 | $71K | Hold |
1,000
| – | – | ﹤0.01% | 2725 |
|
|
2018
Q4 | $45K | Buy |
+1,000
| New | +$52.4K | ﹤0.01% | 2743 |
|
|
2016
Q2 | – | Sell |
-84,400
| Closed | -$2.84M | – | 2649 |
|
|
2016
Q1 | $2.84M | Buy |
+84,400
| New | +$2.86M | ﹤0.01% | 2299 |
|
|
2015
Q3 | – | Sell |
-55,700
| Closed | -$3.46M | – | 2715 |
|
|
2015
Q2 | $3.46M | Buy |
55,700
+10,500
| +23% | +$625K | ﹤0.01% | 2333 |
|
|
2015
Q1 | $2.83M | Buy |
+45,200
| New | +$2.75M | ﹤0.01% | 2361 |
|
Other funds holding ANIP
SCM
TCM
GACM
Fidelity Investments's ANIP Position: Q2 2026 in Review
Fidelity Investments increased its ANI Pharmaceuticals (ANIP) stake by 96% in Q2 2026, buying an estimated $1.45M and bringing the position to 36,848 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2608.
Fidelity Investments first reported a position in ANIP in Q1 2015 and has held it in 31 quarters since. The position peaked at $3.46M in Q2 2015. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.
- Fidelity Investments held 36,848 shares of ANI Pharmaceuticals worth $3.05M as of Q2 2026.
- Fidelity Investments bought 18,071 ANI Pharmaceuticals shares in Q2 2026, an estimated $1.45M.
- ANI Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2608 holding.
- Fidelity Investments first reported a position in ANI Pharmaceuticals in Q1 2015 and has held it in 31 quarters since.
- Fidelity Investments's ANI Pharmaceuticals position peaked at $3.46M in Q2 2015.
- 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.